Russell Investments Group
BLCM

Russell Investments Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Russell Investments Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-620
Closed -$38K – 3062
2018
Q3 		$38K Sell
620
-20
-3% -$1.35K ﹤0.01% 2857
2018
Q2 		$47K Buy
+640
New +$49.9K ﹤0.01% 2814
2018
Q1 		– Sell
-1,010
Closed -$85K – 3032
2017
Q4 		$85K Buy
+1,010
New +$99K ﹤0.01% 2806
2017
Q1 		– Sell
-412
Closed -$57K – 3109
2016
Q4 		$57K Buy
+412
New +$73.1K ﹤0.01% 2961

Other funds holding BLCM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's BLCM Position: Q4 2018 in Review

Russell Investments Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2018, closing a stake of 620 shares — an estimated $38K sold.

Russell Investments Group first reported a position in BLCM in Q4 2016 and held it in 4 quarters. The position peaked at $85K in Q4 2017. 92 funds tracked by Wall St. Rank hold BLCM as of Q4 2018.

  • Russell Investments Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Russell Investments Group sold 620 Bellicum Pharmaceuticals, Inc. shares in Q4 2018, an estimated $38K.
  • Russell Investments Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
  • Russell Investments Group's Bellicum Pharmaceuticals, Inc. position peaked at $85K in Q4 2017.
  • 92 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2018.

Based on Russell Investments Group's 13F filing for Q4 2018, filed 11 Feb 2019.